A Study of Stavudine in HIV-Infected Patients Who Have Not Had Success With Other Anti-HIV Drugs
NCT00002308 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL
Last updated 2011-08-05
Summary
To make stavudine (d4T) available to patients with advanced HIV disease for whom no alternative antiretroviral is satisfactory. To study the safety and efficacy of two dose levels in a twice-daily regimen.
Conditions
- HIV Infections
Interventions
- DRUG
-
Stavudine
Sponsors & Collaborators
- lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 13 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Completion
- 1991-11-30
Countries
- United States
Study Locations
More Related Trials
-
A Study of d4T in Patients With AIDS or AIDS-Related Complex Who Cannot Take AZT
NCT00000686 ·Status: TERMINATED ·Phase: PHASE1
-
A Study of Indinavir Sulfate Given Together With Stavudine to HIV-Positive Patients
NCT00002354 ·Status: COMPLETED ·Phase: NA
-
Dose Optimisation of Stavudine for the Treatment of HIV Infection
NCT02670772 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Effectiveness of a Three-Drug Combination Treatment for Recently Infected or Converted HIV Patients
NCT00007202 ·Status: COMPLETED ·Phase: PHASE2
-
A Comparison of Emtricitabine and Stavudine Used With Didanosine Plus Efavirenz in HIV-Infected Patients Who Have Not Taken Anti-HIV Drugs
NCT00006208 ·Status: UNKNOWN ·Phase: PHASE3
-
The Safety and Effectiveness of Didanosine Plus Stavudine Plus Nevirapine Combined With MKC-442 in HIV-Infected Patients Who Have Not Had Success With Protease Inhibitors
NCT00002418 ·Status: TERMINATED ·Phase: PHASE2
-
A Pilot Open Label Trial of HIV Therapy With d4T (Stavudine), ddI (Didanosine), Nelfinavir and Hydroxyurea in Subjects With Early Asymptomatic HIV Infection
NCT00002176 ·Status: COMPLETED ·Phase: NA
-
The Safety and Effectiveness of Didanosine Plus Stavudine Plus Delavirdine Mesylate Plus MKC-442 in HIV-Infected Patients Who Have Not Had Success With Protease Inhibitors
NCT00002420 ·Status: TERMINATED ·Phase: PHASE2
-
A Pilot Open Label Trial of HIV Therapy With d4T (Stavudine), ddI (Didanosine), Nelfinavir and Hydroxyurea in Subjects With Recent HIV Infection
NCT00002177 ·Status: COMPLETED ·Phase: NA
-
A Study to Compare the Effectiveness of Two Anti-HIV Drug Combinations
NCT00002430 ·Status: COMPLETED ·Phase: NA
-
The Safety and Effectiveness of Nevirapine Plus Nelfinavir in HIV-1 Infected Patients Who Have Taken Stavudine
NCT00002381 ·Status: COMPLETED ·Phase: PHASE1
-
Comparison of Stavudine Used Alone or in Combination With Didanosine in HIV-Infected Children
NCT00000851 ·Status: COMPLETED ·Phase: PHASE2
-
A Randomized, Comparative Trial of Zidovudine (AZT) Versus 2',3'-Didehydro-3'-Deoxythymidine (Stavudine; d4T) in Children With HIV Infection
NCT00000789 ·Status: COMPLETED ·Phase: PHASE2
-
The Effectiveness of Three Drug Combinations in HIV-Infected Patients Who Have Taken Zidovudine for More Than 12 Weeks
NCT00001063 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of the Safety and Effectiveness of Treating Advanced AIDS Patients Between Ages 4 and 22 With 7 Drugs, Some at Higher Than Usual Doses
NCT00001108 ·Status: COMPLETED ·Phase: PHASE1
-
The Safety and Effectiveness of Lamivudine Plus Stavudine or Zidovudine in HIV-Infected Patients Who Have Taken Zidovudine
NCT00002371 ·Status: COMPLETED ·Phase: PHASE3
-
A Randomized, Placebo-Controlled Study of the Safety and Efficacy of Efavirenz, Didanosine, and Stavudine in Combination With or Without Hydroxyurea in Antiretroviral Naive or Experienced HIV-Infected Patients
NCT00002230 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Three Drug Combination Therapies in HIV-Infected Patients Who Have Never Been Treated With Anti-HIV Drugs
NCT00002407 ·Status: COMPLETED ·Phase: NA
-
A Study of Efavirenz in Combination With Stavudine and Didanosine
NCT00002225 ·Status: COMPLETED ·Phase: PHASE2
-
A Multicenter, Open-Label, Randomized, 24-Week Study to Compare the Safety and Activity of Indinavir Sulfate, 800 Mg q 8 h Versus 1,200 Mg q 12 h in Combination With Zidovudine and 3TC
NCT00002208 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Viral Efficacy and Safety of a Reduced Dose of Stavudine (d4T): THE PHOENIX STUDY
NCT00235222 ·Status: UNKNOWN ·Phase: PHASE4
-
A Pilot Study of the Immunologic Reconstitution in HIV-1 Infected Children Receiving Highly Active Antiretroviral Therapy With Combination Ritonavir, Nevirapine and Stavudine
NCT00001688 ·Status: COMPLETED ·Phase: PHASE2
-
The Safety and Effectiveness of Adefovir Dipivoxil Plus Indinavir Combined With Zidovudine or Lamivudine or Stavudine in HIV-Infected Patients Who Have Not Taken Anti-HIV Drugs
NCT00002379 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Boosted Atazanavir (ATV) Versus Non-boosted ATV in Naive Patients
NCT00084253 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of Efavirenz in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs
NCT00002227 ·Status: COMPLETED ·Phase: PHASE2